Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Gildan Activewear Inc. Stock Rises Friday, Still Underperforms Market

Gildan Activewear Inc. Stock Rises Friday, Still Underperforms Market

Dow JonesDow Jones2026/10/09 20:32

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Gildan Activewear Inc. GIL inched 0.55% higher to C$59.82 Friday, in what proved to be an all-around positive trading session for the Canadian market, with the S&P/TSX Composite Index rising 1.48% to 35,664.62. Gildan Activewear Inc. closed 40.4% short of its 52-week high of C$100.44, which the company achieved on February 13th. Trading volume of 391,192 shares remained below its 50-day average volume of 754,248. Data source: Dow Jones Market Data, FactSet. Data compiled October 9, 2026. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires October 09, 2026 16:32 ET (20:32 GMT)

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Gildan Activewear Inc. GIL inched 0.55% higher to C$59.82 Friday, in what proved to be an all-around positive trading session for the Canadian market, with the S&P/TSX Composite Index rising 1.48% to 35,664.62.

Gildan Activewear Inc. closed 40.4% short of its 52-week high of C$100.44, which the company achieved on February 13th.

Trading volume of 391,192 shares remained below its 50-day average volume of 754,248.

Data source: Dow Jones Market Data, FactSet. Data compiled October 9, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

October 09, 2026 16:32 ET (20:32 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials

Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.

智通财经•2026/10/10 06:21